Amgen 2026년 5월 16일 Amgen Inc stock (US0311621009): lungs cancer setback meets steady biotech cash flow - AD HOC NEWS
Amgen 2026년 5월 15일 Alumis pulls back from would-be rival to Amgen’s Tepezza after assessing prospects - Fierce Biotech
Amgen 2026년 5월 14일 Amgen stock (US0311621009): Biotech leader navigates patent cliffs and pipeline momentum - AD HOC NEWS
Amgen 2026년 5월 12일 This Week’s Biopharma News: Amgen Deepens US Manufacturing Push - The Medicine Maker
Amgen 2026년 5월 10일 Quantum firm hailed by Amgen tech leader as an ‘extraordinary platform’ plans IPO - Fierce Biotech
Amgen 2026년 5월 6일 Biopharma Manufacturing Expands in the U.S.: Amgen, Lilly Double Down on Capacity and Next-Gen Production - BioPharm International
Amgen 2026년 5월 4일 Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge? - 24/7 Wall St.
Amgen 2026년 5월 4일 Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge? - Yahoo Finance
Amgen 2026년 5월 4일 Amgen channels another $300M into US outlay, bolstering Puerto Rico biologics expansion - Fierce Pharma
Amgen 2026년 5월 2일 Biopharma bites: Novo rebrands Rybelsus as the Ozempic pill, and Amgen trims its pipeline - FirstWord Pharma
Amgen 2026년 5월 1일 Repatha sales help Amgen overcome Prolia biosimilar hits in 1st quarter - Fierce Pharma